US FDA grants approval for Roivant and Priovant's first oral treatment for a rare skin and muscle disease.

27 Aug 2026 · 19:26 UTC

Observed price moves

ROIV-0.67%15 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.